Seeking Alpha

Cell Therapeutics (CTIC +10.9%) rallies after the FDA says the company's drug pixantrone, which...

Cell Therapeutics (CTIC +10.9%) rallies after the FDA says the company's drug pixantrone, which is under review for adults with non-Hodgkin's lymphoma, will be discussed by an advisory committee in early February.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector